PriceTargets.com logo

NAYA Biosciences - NAYA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $24.00
  • Forecasted Upside: 879.59%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.45 As of 03/21/2025 01:21 PM ET
▲ +0.11 (4.70%)

This chart shows the closing price for NAYA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NAYA Biosciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NAYA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NAYA

Analyst Price Target is $24.00
▲ +879.59% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for NAYA Biosciences in the last 3 months. The average price target is $24.00, with a high forecast of $24.00 and a low forecast of $24.00. The average price target represents a 879.59% upside from the last price of $2.45.

This chart shows the closing price for NAYA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in NAYA Biosciences.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/19/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/21/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/23/2025Maxim GroupUpgradeHold ➝ Buy$24.00
(Data available from 3/21/2020 forward)

News Sentiment Rating

0.35 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/21/2025

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

NAYA Biosciences

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Read More

Today's Range

Now: $2.45
Low: $2.31
High: $2.53

50 Day Range

MA: $4.71
Low: $2.31
High: $9.76

52 Week Range

Now: $2.45
Low: $1.94
High: $42.00

Volume

42,130 shs

Average Volume

26,266 shs

Market Capitalization

$1.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Frequently Asked Questions

What sell-side analysts currently cover shares of NAYA Biosciences?

The following Wall Street research analysts have issued reports on NAYA Biosciences in the last twelve months: Maxim Group.
View the latest analyst ratings for NAYA.

What is the current price target for NAYA Biosciences?

0 Wall Street analysts have set twelve-month price targets for NAYA Biosciences in the last year. Their average twelve-month price target is $24.00, suggesting a possible upside of 925.6%. Maxim Group has the highest price target set, predicting NAYA will reach $24.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $24.00 for NAYA Biosciences in the next year.
View the latest price targets for NAYA.

What is the current consensus analyst rating for NAYA Biosciences?

NAYA Biosciences currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NAYA will outperform the market and that investors should add to their positions of NAYA Biosciences.
View the latest ratings for NAYA.

What other companies compete with NAYA Biosciences?

Other companies that are similar to NAYA Biosciences include Aethlon Medical, Autonomix Medical, Check-Cap, Nuwellis and Plus Therapeutics. Learn More about companies similar to NAYA Biosciences.

How do I contact NAYA Biosciences' investor relations team?

NAYA Biosciences' physical mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The company's listed phone number is 978-878-9505 and its investor relations email address is [email protected]. The official website for NAYA Biosciences is www.invobioscience.com. Learn More about contacing NAYA Biosciences investor relations.